Balfour, J A <br/><br/>
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.  [electronic resource] 

 -  PharmacoEconomics  Aug 1996 
 - 164-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1170-7690 
<br/><br/><label>Standard No.: </label>10.2165/00019053-199610020-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ceftizoxime--analogs & derivatives<br/>Community-Acquired Infections--drug therapy<br/>Cost Control<br/>Humans<br/>Prodrugs--economics<br/>Respiratory Tract Infections--drug therapy<br/>Cefpodoxime Proxetil